Arabic Arabic English English French French German German
dark

Fractyl’s Latest Milestone: Breakthrough Device Designation

The Lexington, MA-based company is developing a therapy that uses ablation to ablate a portion of the duodenum mucosa, which could have the potential to improve glucose control in patients struggling to manage diabetes. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Direct Pay Healthcare Marketplace Sesame Nabs $24M to Expand its Nationwide Telehealth Offerings

Next Post

Physical activity reduces cardiovascular risk in rheumatic patients

Related Posts
Total
0
Share